The Epstein-Barr virus (EBV) proteins EBNA1, EBNA2, EBNA3A, EBNA3C, LMP1 and EBNA-LP are essential for the in vitro immortalization of primary B lymphocytes by EBV. EBNA2 is a transcriptional activator of viral and cellular genes. Both EBNA3A and EBNA3C have been shown to specifically inhibit EBNA2-activated transcription by direct interaction with RBP-Jk, a cellular DNA-binding factor known to recruit EBNA2 to EBNA2-responsive genes. This interaction interferes with the binding of RBP-Jk to DNA in vitro, and this is probably the mechanism by which EBNA3A and EBNA3C repress EBNA2-acti- vated transcription in vivo. EBNA3A and EBNA3C also directly repress transcription when tethered to a promoter via the DNA-binding domain of the yeast Gal4 protein. As RBP-Jk has been previously shown to be a repressor in mammalian cells, this repression could be due to the recruitment of RBP-Jk by Gal4-EBNA3A and 3C. In this study, we have precisely mapped the domain of EBNA3A involved in the interaction with RBP-Jk and we have shown that interaction with RBP-Jk is not required for the Gal4-EBNA3A-mediated repression. Furthermore, we have characterized in EBNA3A a domain of 143 amino acids which is necessary and sufficient for EBNA3A-dependent repression.
AlldayM. J.,
FarrellP. J.1994; Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells. Journal of Virology 68:3491–3498
BainM.,
WatsonR. J.,
FarrellP. J.,
AlldayM. J.1996; Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. Journal of Virology 70:2481–2489
CalenderA.,
BillaudM.,
AubryJ.-P.,
BanchereauJ.,
VuillaumeM.,
LenoirG. M.1987; Epstein -Barr virus (EBV) induces expression of B- cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proceedings of the National Academy of Sciences, USA 84:8060–8064
CohenJ. F.,
WangF.,
MannickJ.,
KieffE.1989; Epstein -Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proceedings of the National Academy of Sciences, USA 86:9558–9562
DouS.,
ZengX.,
CortesP.,
Erdjument-BromageH.,
TempsP.,
HonjoT.,
ValesL. D.1994; The recombination signal sequence-binding protein RBP-2N functions as a transcriptional repressor. Molecular and Cellular Biology 14:3310–3319
FahraeusR.,
JanssonA.,
RickstenA.,
SjöblomA.,
RymoL.1990; Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proceedings of the National Academy of Sciences, USA 87:7390–7394
GrossmanS. R.,
JohannsenE.,
TongX.,
YalamanchiliR.,
KieffE.1994; The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jk recombination signal binding protein. Proceedings of the National Academy of Sciences, USA 91:7568–7572
HammerschmidtW. B.,
SugdenB.,
BaichwalV.1989; The transforming domain alone of latent membrane protein of Epstein-Barr virus is toxic when expressed at high levels. Journal of Virology 63:2469–24 75
HenkelT.,
LingP. D.,
HaywardL. S. D.,
PetersonM. G.1994; Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jk
. Science 265:92–95
KallinB.,
DillnerJ.,
ErnbergI.,
Ehlin-HenrikssonB.,
RosenA.,
HenleW.,
KleinG.1986; Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proceedings of the National Academy of Sciences, USA 83:1499–1503
KayeK. M.,
IzumiK. M.,
KieffE.1993; Epstein-Barr virus latent membrane protein 1 is essential for B lymphocytes growth trans-formation. Proceedings of the National Academy of Sciences, USA 68:9150–9154
KempkesB.,
SpitkovskyD.,
Jansen-DürrP.,
EllwartJ. W.,
KremmerE.,
DelecluseH.-J.,
RottenbergerC.,
BornkammG. W.,
HammerschmidtW.1995; B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO Journal 14:88–96
KieffE. D.1996; Epstein-Barr virus. In Fields Virology, 3rd edn. pp 2343–2396FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Edited by Philadelphia: Lippincott-Raven;
KnustonJ. C.1990; The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for cell immortalization. Journal of Virology 64:2530–2536
KrauerK. G.,
KienzleN.,
YoungD. B.,
SculleyT. B.1996; Epstein-Barr nuclear antigen-3 and-4 interact with RBP2N a major isoform of RBP-Jk in B lymphocytes. Virology 226:346–353
LingP. D.,
RawlinsD. R.,
HaywardS. D.1993; The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proceedings of the National Academy of Sciences, USA 90:9237–9241
MannickJ. B.,
CohenJ. L.,
BirkenbachM.,
MarchiniA.,
KieffE.1991; The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs (EBNA-LP) is important in B-lymphocyte transformation. Journal of Virology 65:6826–6837
MartinJ. M.,
VeisD.,
KorsmeyerS. J.,
SugdenB.1993; Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. Journal of Virology 67:5269–5278
ParkerG. A.,
CrookT.,
BainM.,
SaraE. A.,
FarrellP. J.,
AlldayM. J.1996; Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13:2541–2549
RobertsonE. S.,
GrossmanS.,
JohannsenE.,
MillerC.,
LinJ.,
TomkinsonB.,
KieffE.1995; Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein Jk
. Journal of Virology 69:3108–3116
RobertsonE. S.,
LinJ.,
KieffE.1996; The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B and 3C interact with RBPJK. Journal of Virology 70:3068–3074
RooneyC. M.,
BrimmellM.,
BuschleM.,
AllanG.,
FarrellP. J.,
KolmanJ. L.1992; regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. Journal of Virology 66:496–504
SilinsS. L.,
SculleyT. B.1994; Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4. Virology 202:16–24
SinclairA. J.,
PalmeroI.,
PetersG.,
FarrellP. J.1994; EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO Journal 13:3321–3328
SungN. S.,
KenneyS.,
GutschD.,
PaganoJ. S.1991; EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. Journal of Virology 65:2164–2169
TomkinsonB.,
RobertsonE.,
KieffE.1993; Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. Journal of Virology 67:2014–2025
WaltzerL.,
BourillotP. Y.,
SergeantA.,
ManetE.1995; RBP-JK repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. Nucleic Acids Research 23:4939–4945
WaltzerL.,
LogeatF.,
BrouC.,
IsraelA.,
SergeantA.,
ManetE.1994; The human JK recombination signal sequence binding protein (RBP-Jk ) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO Journal 13:5633–5638
WaltzerL.,
PerricaudetM.,
SergeantA.,
ManetE.1996; Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-JK- EBNA2-activated transcription by inhibiting the binding of RBP-JK to DNA. Journal of Virology 70:5909–5915
WangF.,
GregoryC.,
SampleC.,
RoweM.,
LiebowitzD.,
MurrayR.,
RickinsonA.,
KieffE.1990a; Epstein-Barr virus latent membrane protein (LMP1) and nuclear antigen 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. Journal of Virology 64:2309–2318
WebsterN.,
GreenS.,
TassetD.,
PonglikitmongkolM.,
ChambonP.1989; The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon. EMBO Journal 8:1441–1446
WoisetchlaegerM.,
YandavaC. N.,
FurmanskiL. A.,
StromingerJ. L.,
SpeckS.1990; Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. 87:1725–1729
YalamanchiliR.,
TongX.,
GrossmanS.,
JohannsenE.,
MosialosG.,
KieffE.1994; Genetic and biochemical evidence that EBNA2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology 204:634–641
ZhaoB.,
MarshallD. R.,
SampleC. E.1996; A conserved domain of the Epstein-Barr virus nuclear antigen 3A and 3C binds to a discrete domain of JK. Journal of Virology 70:4228–4236
Zimber-StroblU.,
StroblL. J.,
MeitingerC.,
HinrichsR.,
SakaiT.,
FurukawaT.,
HonjoT.,
BornkammG.1994; Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jk, the homologue of Drosophila Suppressor of Hairless
. EMBO Journal 13:4973–4982